Jing Z Lin

US Patent:

20210386689, Dec 16, 2021

Filed:

Oct 30, 2019

Appl. No.:

17/286155

Inventors:

- Marlborough MA, US
Jing LIN - Marlborough MA, US

Assignee:

Sunovion Pharmaceuticals Inc. - Marlborough MA

International Classification:

A61K 31/135
A61K 31/137
A61K 31/536
A61K 31/55
A61K 31/496
A61K 31/427

Abstract:

Provided herein are methods of treating central nervous system (CNS) disorders (e.g., Binge Eating Disorder (BED), Attention-Deficit/Hyperactivity Disorder (ADHD), etc.) with a dasotraline therapy while avoiding adverse drug interactions.

US Patent:

20170081694, Mar 23, 2017

Filed:

Dec 6, 2016

Appl. No.:

15/370033

Inventors:

- Basel, CH
Jing Lin - Belmont MA, US

International Classification:

C12Q 1/00
G01N 27/327

Abstract:

An electrochemical test sensor is adapted to measure glucose and correct for the oxygen effect in a fluid sample. The test sensor comprises a base, first and second working electrodes, and a counter electrode. The first working electrode includes glucose oxidase, a mediator and peroxidase. The second working electrode includes glucose oxidase and the mediator. The first working electrode, the second working electrode and the counter electrode are located on the base. In other embodiments, an electrochemical test sensor is adapted to measure cholesterol, lactate, pyruvate or xanthine and correct for the oxygen effect in a fluid sample.